SOLOSEC is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Secnidazole.
Product ID | 27437-051_2d4f4392-eef9-470e-83a0-6fe7a695ecd9 |
NDC | 27437-051 |
Product Type | Human Prescription Drug |
Proprietary Name | SOLOSEC |
Generic Name | Secnidazole |
Dosage Form | Granule |
Route of Administration | ORAL |
Marketing Start Date | 2017-10-30 |
Marketing Category | NDA / NDA |
Application Number | NDA209363 |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Substance Name | SECNIDAZOLE |
Active Ingredient Strength | 2 g/4.8g |
Pharm Classes | Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-10-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209363 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-03-19 |
Marketing Category | NDA |
Application Number | NDA209363 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-30 |
Ingredient | Strength |
---|---|
SECNIDAZOLE | 2 g/4.8g |
SPL SET ID: | 551e43d5-f700-4d6e-8029-026f8a8932ff |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
27437-051 | SOLOSEC | secnidazole |
64811-401 | Solosec | SECNIDAZOLE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SOLOSEC 86696432 5498160 Live/Registered |
Symbiomix Therapeutics, LLC 2015-07-17 |